However, in breast cancer, genome-wide analysis of YAP1/TAZ-binding sites showed that nearly 91% of YAP1/TAZ-bound cis-regulatory regions coincided with enhancer elements located at a distance from transcription start sites [46]. This evidence concerns the gene YAP1 and breast cancer.